Ovid Therapeutics, Inc.

Ovid Therapeutics, Inc. price (OVID)

$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
High
Low
Prev. Close

About Ovid Therapeutics, Inc.

Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Sector
Health Technology
CEO
Jeremy Max Levin
Industry
Pharmaceutical
Exchange
NAS

Top Stories

Coming soon.